HHSC: Drug Utilization Review Board

Regulatory
May 27, 2020
  • Twitter
  • Facebook
  • Google+
  • Linkedin
The Drug Utilization Review Board develops and submits recommendations for the preferred drug list, suggests clinical prior authorizations on outpatient prescription drugs, recommends education interventions for Medicaid providers, and reviews drug usage across Medicaid programs. The DUR board is composed of 20 total members: 18 physicians and pharmacists providing services across the entire population of Medicaid and representing different specialties; two representatives from Medicaid managed care organizations as nonvoting members; and a consumer advocate representing people enrolled in the program. Physician/pharmacist positions Robert L. Hogue, M.D., F.A.A.F.M. (Brownwood) (Chair) J. Nile Barnes, Pharm. D., BCPS (Dripping Springs) Scott Blaszczyk, Pharm.D., BCGP (Dallas) Deborah E. Briggs, M.D. (Austin) Marlo Brawner, M.D. (Livingston) Deeatra S. Craddock, Pharm. D, BCACP (Carrollton) Jennifer Fix, Pharm. D (Burleson) Connie Gelineau, Pharm.D. (Ri

Subscribe to gain full access to all of our must-have reports and videos

OR

Log in